Immune-mediated antitumor effect of a transplanted lymph node

Area of Science:

• Immunology
• Surgical Oncology
• Cancer Research

Background:

• Lymph node (LN) transplantation is a clinical method for lymphatic reconstruction, primarily for lymphedema.
• The role of transplanted LNs in immune surveillance and antitumor responses remains largely uninvestigated.

Purpose of the Study:

• To determine if a single transplanted non-vascularized lymph node, termed a tumor-draining transplanted lymph node (TDTLN), can mediate an antitumor effect.
• To compare the immune function of TDTLNs with naturally occurring tumor-draining popliteal lymph nodes (TDPLNs).

Main Methods:

• Mice were inoculated with melanoma cells and subjected to popliteal lymph node (PLN) resection or LN transplantation.
• Tumor growth, LN, and lung metastases were evaluated.
• Immunohistochemistry and fluorescence-activated cell sorting (FACS) were used to analyze lymphocyte presence, expansion, and cytokine expression in transplanted and native LNs.

Main Results:

• PLN resection aggravated LN and lung metastases, while LN transplantation significantly decreased them.
• Transplanted LNs (TDTLNs) retained T-cells and B-cells, with lymphocyte expansion observed, though differing from TDPLNs.
• Both TDTLNs and TDPLNs expressed immunostimulatory cytokines, with differences in lymphocyte homing contributing to varying antitumor effects.

Conclusions:

• Non-vascularized lymph node transplantation demonstrates an immune-mediated antitumor effect.
• Transplanted LNs can contribute to immune surveillance and potentially control tumor progression.
• Understanding lymphocyte homing mechanisms in transplanted LNs could optimize cancer immunotherapy strategies.